Outcome and molecular characteristics of non-invasive encapsulated follicular variant of papillary thyroid carcinoma with oncocytic features
Authors:
- 28 January 2019
- journal article
- research article
- Published by Springer Nature in Endocrine
- Vol. 64 (1) , 97-108
Abstract
In 2016, non-invasive encapsulated follicular variant of papillary thyroid carcinoma (NI-EFVPTC) was renamed as noninvasive thyroid follicular neoplasm with papillary-like nuclear features (NIFTP). However, as the study cohort did not mention tumors with oncocytic features, such lesions are still labeled by some as FVPTC. It is therefore crucial to evaluate the outcome and molecular profile of oncocytic NI-EFVPTC.Keywords
Funding Information
- National Cancer Institute (P30CA008748)
- Agenzia Italiana del Farmaco, Ministero della Salute (RF-2011-02350857)
This publication has 33 references indexed in Scilit:
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- Late Recurrences of Thyroid Carcinoma 24 Years after a Complete Remission: When Monitoring Should be Stopped?World Journal of Nuclear Medicine, 2012
- Integrative genomics viewerNature Biotechnology, 2011
- Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patternsLaboratory Investigation, 2010
- Molecular features of thyroid oncocytic tumorsMolecular and Cellular Endocrinology, 2010
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009
- Encapsulated Papillary Thyroid Carcinoma: A Clinico-Pathologic Study of 106 Cases with Emphasis on Its Morphologic Subtypes (Histologic Growth Pattern)Thyroid®, 2009
- Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumorsProceedings of the National Academy of Sciences, 2007
- Follicular variant of papillary thyroid carcinomaCancer, 2006
- Defective Oxidative Phosphorylation in Thyroid Oncocytic Carcinoma Is Associated with Pathogenic Mitochondrial DNA Mutations Affecting Complexes I and IIICancer Research, 2006